Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
@article{Hannan2008DrugelutingSV, title={Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.}, author={Edward L. Hannan and Chuntao Wu and Gary D. Walford and Alfred T. Culliford and Jeffrey Gold and Craig R. Smith and Robert S. D. Higgins and Russell E Carlson and Robert H. Jones}, journal={The New England journal of medicine}, year={2008}, volume={358 4}, pages={ 331-41 } }
BACKGROUND
Numerous studies have compared the outcomes of two competing interventions for multivessel coronary artery disease: coronary-artery bypass grafting (CABG) and coronary stenting. However, little information has become available since the introduction of drug-eluting stents.
METHODS
We identified patients with multivessel disease who received drug-eluting stents or underwent CABG in New York State between October 1, 2003, and December 31, 2004, and we compared adverse outcomes (death…
372 Citations
Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease: Three-Year Follow-Up Results From a Single Institution
- MedicineCirculation
- 2009
In a cohort of patients with multivessel disease, CABG was associated with lower rates of death, myocardial infarction, and target-vessel revascularization than drug-eluting stents in a 3-year follow-up.
Drug-eluting stents versus bypass surgery for multivessel coronary disease
- Medicine
- 2009
Focus is placed on the recent data and evidence for long-term outcomes in patients treated with DES or CABG for complex multivessel coronary disease, including unprotected left main disease.
Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease.
- MedicineCirculation journal : official journal of the Japanese Circulation Society
- 2010
CABG might be associated with cost-effectiveness and could be still the first revascularization strategy for ULMCA disease in the era of drug-eluting stents.
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents.
- MedicineThe Annals of thoracic surgery
- 2013
Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease.
- MedicineJournal of the American College of Cardiology
- 2014
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
- MedicineKorean circulation journal
- 2017
Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.
Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
- MedicineThe American journal of cardiology
- 2017
Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention
- Medicine
- 2010
Current evidence from randomized trials, a meta-analysis and several observation studies are reviewed, and the comparative effectiveness of PCI and OPCAB remains uncertain.
Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease
- MedicineCirculation
- 2011
Angiographic CR with drug-eluting stent implantation or coronary artery bypass grafting did not improve long-term clinical outcomes in patients with multivessel coronary disease, and this finding supports the strategy of ischemia-guided revascularization.
Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease.
- MedicineThe Annals of thoracic surgery
- 2019
References
SHOWING 1-10 OF 41 REFERENCES
Long-term outcomes of coronary-artery bypass grafting versus stent implantation.
- MedicineThe New England journal of medicine
- 2005
For patients with two or more diseased coronary arteries, CABG is associated with higher adjusted rates of long-term survival than stenting.
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
- MedicineThe New England journal of medicine
- 2003
In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
- MedicineThe New England journal of medicine
- 2001
As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction, however, stenting is associated with a greater need for repeated revascularization.
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.
- MedicineJournal of the American College of Cardiology
- 2001
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
- MedicineAnnals of Internal Medicine
- 2007
It is found that survival at 10 years was similar for CABG and PCI, even among diabetic patients, and the evidence from RCTs on the comparative effectiveness of PCI and CABGs was evaluated.
A Prospective Randomized Trial Comparing Stenting to Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA Trial
- Medicine
- 2000
Both stent implantation and CABG are safe and highly effective treatments to relieve symptoms in patients with isolated, proximal left anterior descending coronary artery stenosis, and both are associated with a low and comparable incidence of death and myocardial infarction.
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
- MedicineThe New England journal of medicine
- 2002
As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
- Medicine, BiologyJAMA
- 2007
The extended use of clopidogrel in patients with DES may be associated with a reduced risk for death and death or MI, and the appropriate duration for clopIDogrel administration can only be determined within the context of a large-scale randomized clinical trial.
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.
- MedicineEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
- 2005
The low incidence of MACCE and repeat revascularisation in ARTS II suggests that contemporary PCI with sirolimus-eluting stents is safe and efficacious for the treatment of multivessel coronary artery disease.